Results for tag: "Shigella Test"

The Shigella Test market is a subset of the larger Infectious Disease Testing market. It is focused on the detection of Shigella bacteria, which can cause a range of gastrointestinal illnesses. Tests for Shigella are used to diagnose and monitor the spread of the bacteria, and to inform treatment decisions. Tests are typically performed on stool samples, and can be used to detect the presence of Shigella bacteria, as well as to identify the specific strain. The Shigella Test market is composed of a range of diagnostic companies, including both large multinationals and smaller, specialized firms. Examples of companies in the market include Abbott, Becton Dickinson, Cepheid, DiaSorin, Hologic, and Quidel. Show Less Read more